Thibault Houles
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
CDK12 inhibition reveals melanoma dependence on the RUNX1/CBFβ complex for genomic stability.
Journal: Cell reports
Published: February 27, 2025
The expanding landscape of canonical and non-canonical protein phosphorylation.
Journal: Trends in biochemical sciences
Published: March 29, 2024
The CDK12 inhibitor SR-4835 functions as a molecular glue that promotes cyclin K degradation in melanoma.
Journal: Cell death discovery
Published: June 30, 2023
Multi-Level Control of the ATM/ATR-CHK1 Axis by the Transcription Factor E4F1 in Triple-Negative Breast Cancer.
Journal: International journal of molecular sciences
Published: July 08, 2022
CDK12 is hyperactivated and a synthetic-lethal target in BRAF-mutated melanoma.
Journal: Nature communications
Published: September 16, 2021
RIOK2 phosphorylation by RSK promotes synthesis of the human small ribosomal subunit.
Journal: PLoS genetics
Published: April 29, 2021
RSK Regulates PFK-2 Activity to Promote Metabolic Rewiring in Melanoma.
Journal: Cancer research
Published: July 21, 2017
Defining the role of the RSK isoforms in cancer.
Journal: Seminars in cancer biology
Published: January 30, 2017
E4F1 controls a transcriptional program essential for pyruvate dehydrogenase activity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 14, 2016
Description of an optimized ChIP-seq analysis pipeline dedicated to genome wide identification of E4F1 binding sites in primary and transformed MEFs.
Journal: Genomics data
Published: June 26, 2015
Last Updated: 09/26/2026